MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$221,171K
Cash and cash
equivalents
$130,893K
Accounts receivable, net
$38,116K
Inventory
$34,948K
Collaboration receivable, net
$20,507K
Prepaid expenses and
other current assets
$16,100K
Short-term deposits
$9,175K
Other receivable, net
$267K
Property and equipment,
gross
$606K
Total current assets
$471,177K
Right-of-use asset, net
$1,212K
Property and equipment,
net
$177K
Restricted cash
$102K
Accumulated depreciation
$429K
Total assets
$472,668K
Total liabilities and
stockholders equity
$472,668K
Total liabilities
$431,046K
Total stockholders
equity
$41,622K
Accumulated deficit
-$1,549,253K
Total long-term
liabilities
$344,872K
Total current
liabilities
$86,174K
Additional paid-in capital
$1,590,855K
Accumulated other
comprehensive gain
$11K
Common stock, 0.0001
par value,...
$9K
Royalty interest
financing liability, less...
$343,965K
Right-of-use liability, less
current portion
$907K
Accrued expenses and
other current...
$74,843K
Accounts payable
$10,843K
Current portion of
right-of-use liability
$487K
Current portion of
capital lease
$1K
Back
Back
Balance Sheet
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)
source: myfinsight.com